The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pivotal phase III COMPOSE trial will compare 177Lu-edotreotide with best standard of care for well-differentiated aggressive grade 2 and grade 3 gastroenteropancreatic neuroendocrine tumors.
 
Thorvardur Ragnar Halfdanarson
Consulting or Advisory Role - Advanced Accelerator Applications (Inst); Curium Pharma; Ipsen (Inst); Lexicon (Inst); ScioScientific; TERUMO
Research Funding - Advanced Accelerator Applications (Inst); Agios (Inst); Basilea (Inst); Ipsen (Inst); Novartis (Inst); Thermo Fisher Scientific (Inst); Turnstone Bio (Inst)
 
Diane Lauren Reidy
Honoraria - Novartis
Consulting or Advisory Role - Advanced Accelerator Applications; Chiasma; ITM Oncologics; Lexicon
Research Funding - Ipsen; Merck; Novartis
 
Namrata Vijayvergia
Stock and Other Ownership Interests - Pfizer (I)
Consulting or Advisory Role - HalioDx; Lexicon; QED Therapeutics; Sun Pharma
Research Funding - Bayer
 
Daniel M. Halperin
Consulting or Advisory Role - Abbvie; Advanced Accelerator Applications; Chiasma; Chimeric Therapeutics; Curium Pharma; Ipsen; Isotopen Technologien; Lexicon; Novartis; Novartis; Progenics; Radiomedix
Research Funding - Advanced Accelerator Applications (Inst); Genentech/Roche (Inst); Isotopen Technologien (Inst); Tarveda Therapeutics (Inst); Thermo Fisher Scientific (Inst)
 
Grace Goldstein
Stock and Other Ownership Interests - Dicerna; Eckert and Ziegler; Johnson & Johnson; Merck
Consulting or Advisory Role - Ipsen; Isotopen Technologien
 
Grace Kong
Consulting or Advisory Role - Isotopen Technologien (Inst)
Speakers' Bureau - Isotopen Technologien (Inst); SAM Nordic (Inst)
Research Funding - Clarity Pharmaceuticals (Inst); Cyclotek (Inst); Ipsen (Inst); Pfizer (Inst)
 
Michael Michael
Consulting or Advisory Role - Ipsen; Isotopen Technologien; Merck
Research Funding - Ipsen
Travel, Accommodations, Expenses - Novartis
 
Simone Leyden
Consulting or Advisory Role - Isotopen Technologien
 
Simona Grozinsky-Glasberg
Consulting or Advisory Role - AAA HealthCare; Isotopen Technologien
Research Funding - Ipsen; Novartis
 
Halfdan Sorbye
Honoraria - Ipsen; Nordic Bioscience; Pierre Fabre; SAM Nordic
Consulting or Advisory Role - AAA HealthCare; Amgen; Bayer; Hutchison MediPharma; Isotopen Technologien
 
Kjell E. Oberg
Honoraria - Camurus; Ipsen; Isotopen Technologien
Consulting or Advisory Role - Camurus; Isotopen Technologien
Speakers' Bureau - Ipsen
 
Cristina Sierras
Employment - Isotopen Technologien
 
Philip Harris
Employment - ITM Oncologics
Stock and Other Ownership Interests - Crinetics Pharmaceuticals; ITM Oncologics
Consulting or Advisory Role - Crinetics Pharmaceuticals